India Clears GSK For ‘Quick' Trials Of H1N1 Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
India has given its okay for multinational drug maker GlaxoSmithKline to streamline usual procedures and conduct quick trials of an H1N1 flu vaccine in India. The move is expected to make the GSK vaccine available in India by the end of the year, probably as early as December. India's health ministry has ordered 10 million doses of the vaccine if the trials prove successful, a move that encouraged GSK to test the vaccine in the country. The government plans to conduct its own trials simultaneously with GSK's. (Click here for more